416 related articles for article (PubMed ID: 19475531)
1. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
[TBL] [Abstract][Full Text] [Related]
2. New insights into the pathogenesis of vitiligo: imbalance of epidermal cytokines at sites of lesions.
Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabiani M; Fabbri P
Pigment Cell Res; 2002 Apr; 15(2):87-92. PubMed ID: 11936274
[TBL] [Abstract][Full Text] [Related]
3. Less keratinocyte-derived factors related to more keratinocyte apoptosis in depigmented than normally pigmented suction-blistered epidermis may cause passive melanocyte death in vitiligo.
Lee AY; Kim NH; Choi WI; Youm YH
J Invest Dermatol; 2005 May; 124(5):976-83. PubMed ID: 15854039
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M.
Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G
J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274
[TBL] [Abstract][Full Text] [Related]
5. Immunolocalization of tenascin-C in vitiligo.
Abdou AG; Maraee AH; Shoeib MA; Elbana R
Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
[TBL] [Abstract][Full Text] [Related]
6. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
7. Melanocyte-keratinocyte cross-talk in vitiligo.
Touni AA; Shivde RS; Echuri H; Abdel-Aziz RTA; Abdel-Wahab H; Kundu RV; Le Poole IC
Front Med (Lausanne); 2023; 10():1176781. PubMed ID: 37275386
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-1 and its A and B receptors: are they possibly involved in vitiligo?
Aly DG; Salem SA; Abdel-Hamid MF; Youssef NS; El Shaer MA
Acta Dermatovenerol Croat; 2013; 21(1):12-8. PubMed ID: 23683481
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of glutathione S-transferase leads to excess 4-hydroxy-2-nonenal and H(2)O(2) and impaired cytokine pattern in cultured keratinocytes and blood of vitiligo patients.
Kostyuk VA; Potapovich AI; Cesareo E; Brescia S; Guerra L; Valacchi G; Pecorelli A; Deeva IB; Raskovic D; De Luca C; Pastore S; Korkina LG
Antioxid Redox Signal; 2010 Sep; 13(5):607-20. PubMed ID: 20070240
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-33 affects cytokine production by keratinocytes in vitiligo.
Li P; Ma H; Han D; Mou K
Clin Exp Dermatol; 2015 Mar; 40(2):163-70. PubMed ID: 25251808
[TBL] [Abstract][Full Text] [Related]
12. The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis.
Cario-André M; Pain C; Gauthier Y; Taïeb A
Pigment Cell Res; 2007 Oct; 20(5):385-93. PubMed ID: 17850512
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo and epidermal microenvironment: possible involvement of keratinocyte-derived cytokines.
Moretti S; Spallanzani A; Amato L; Hautmann G; Gallerani I; Fabbri P
Arch Dermatol; 2002 Feb; 138(2):273-4. PubMed ID: 11843662
[No Abstract] [Full Text] [Related]
14. Basic fibroblast growth factor and tumour necrosis factor alpha in vitiligo and other hypopigmented disorders: suggestive possible therapeutic targets.
Seif El Nasr H; Shaker OG; Fawzi MM; El-Hanafi G
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):103-8. PubMed ID: 22151832
[TBL] [Abstract][Full Text] [Related]
15. Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis.
Lee AY; Youm YH; Kim NH; Yang H; Choi WI
Br J Dermatol; 2004 Nov; 151(5):995-1003. PubMed ID: 15541077
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis.
Seleit I; Bakry OA; Abdou AG; Dawoud NM
Ann Diagn Pathol; 2014 Jun; 18(3):117-24. PubMed ID: 24560443
[TBL] [Abstract][Full Text] [Related]
17. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
Kim NH; Lee AY
Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
[TBL] [Abstract][Full Text] [Related]
18. Abnormal nuclear expression of aquaporin-3 in lesional and perilesional skin of vitiligo patients: A novel immunohistochemical finding.
Gamil H; Assaf M; Khater M; Fawzy M
J Cosmet Dermatol; 2023 Mar; 22(3):1063-1070. PubMed ID: 36437598
[TBL] [Abstract][Full Text] [Related]
19. Downregulated melanogenic paracrine cytokine linkages in hypopigmented palmoplantar skin.
Hasegawa J; Goto Y; Murata H; Takata M; Saida T; Imokawa G
Pigment Cell Melanoma Res; 2008 Dec; 21(6):687-99. PubMed ID: 19086131
[TBL] [Abstract][Full Text] [Related]
20. Type-1 cytokines regulate MMP-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
Boukhedouni N; Martins C; Darrigade AS; Drullion C; Rambert J; Barrault C; Garnier J; Jacquemin C; Thiolat D; Lucchese F; Morel F; Ezzedine K; Taieb A; Bernard FX; Seneschal J; Boniface K
JCI Insight; 2020 Jun; 5(11):. PubMed ID: 32369451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
